KKR, a global investment firm, announced, in partnership with Flerie, the formation of a new global pharma services platform, Frontier Biosolutions (Frontier), which will invest in a portfolio of companies focused on specialized pharmaceutical services to advanced therapeutics customers. Frontier will invest in differentiated scientific capabilities and proprietary technology platforms that address critical bottlenecks in…
KKR, a global investment firm, announced that KKR has agreed to acquire Clinisupplies, a market leader in continence care products in the UK, from Healthium. Clinisupplies’ management team will continue to hold a minority position. Financial details of the transaction were not disclosed. Clinisupplies is a UK-based manufacturer and distributor of continence care products, including urinary collecting devices and…
Global investment firm KKR and Biosynth Carbosynth, a life sciences reagents and custom synthesis and manufacturing services company, announced that KKR has agreed to acquire Biosynth Carbosynth from Armira and CEO Dr. Urs Spitz. Financial details of the transaction were not disclosed. Dr. Spitz and senior managers of the company will retain a significant ownership…